14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of XLO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Xilio Therapeutics, Inc. stock upgraded to Buy Candidate.
(Updated on Apr 24, 2024)

Buy or Hold candidate since Apr 02, 2024 Loss -28.38% PDF

The Xilio Therapeutics, Inc. stock price gained 0.95% on the last trading day (Wednesday, 24th Apr 2024), rising from $1.05 to $1.06. During the last trading day the stock fluctuated 9.90% from a day low at $1.01 to a day high of $1.11. The price has been going up and down for this period, and there has been a -17.19% loss for the last 2 weeks. Volume fell on the last day by -149 thousand shares and in total, 297 thousand shares were bought and sold for approximately $314.32 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 76.40% during the next 3 months and, with a 90% probability hold a price between $1.53 and $3.06 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

XLO Signals & Forecast

A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -30.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Xilio Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.17. On a fall, the stock will find some support from the long-term average at approximately $1.01. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.

Support, Risk & Stop-loss for Xilio Therapeutics, Inc. stock

Xilio Therapeutics, Inc. finds support from accumulated volume at $1.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.100 between high and low, or 9.90%. For the last week the stock has had daily average volatility of 11.42%.

Our recommended stop-loss: $1.00 (-5.46%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (XLO) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Xilio Therapeutics, Inc. to open at $1.06, and during the day (based on 14 day Average True Range), to move between $0.89 and $1.23, which gives a possible trading interval of +/-$0.167 (+/-15.78%) up or down from last closing price. If Xilio Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 31.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.05 (0.94%) than the resistance at $1.08 (1.89%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Xilio Therapeutics, Inc. stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.050 Buy Candidate Upgraded

Predicted Opening Price for Xilio Therapeutics, Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$1.06 ( 0%) $1.06

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for XLO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.16 9.43 %
R2 1.12 5.83 %
R1 1.10 3.60 %
Current price: 1.06
Support S1 1.02 -3.60 %
S2 1.00 -5.83 %
S3 0.96 -9.43 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.30 22.64 %
R2 1.21 14.15 %
R1 1.08 1.89 %
Current price 1.06
Support S1 1.05 -0.94%
S2 0.82 -22.64%
S3 0.799 -24.62%

FAQ

What is the symbol for Xilio Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Xilio Therapeutics, Inc. is XLO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Xilio Therapeutics, Inc. Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Xilio Therapeutics, Inc. Stock?
Xilio Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Xilio Therapeutics, Inc. Stock.

What's the current price of Xilio Therapeutics, Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Xilio Therapeutics, Inc. (XLO) share was $1.06.

What is the 52-week high and low for Xilio Therapeutics, Inc. Stock?
The 52-week high for Xilio Therapeutics, Inc. Stock is $3.39 and the 52-week low is $0.490.

What is the market capitalization of Xilio Therapeutics, Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Xilio Therapeutics, Inc. is 38.758M.

When is the next earnings date for Xilio Therapeutics, Inc.?
The upcoming earnings date for Xilio Therapeutics, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Xilio Therapeutics, Inc.

Xilio Therapeutics. Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, ... XLO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT